Amarin Corp. plc (AMRN) Stock Quote

Detailed Quote for Amarin Corp. plc (AMRN)

After Hours: $ 8.45

0.05 (+0.60%)

Volume: 2 k

4:53 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

May 31, 2011

Close: 19.87

52 Week Low

December 15, 2011

Close: 5.99

Today

Last Price
8.40

Change $
0.22

Change %
2.55%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
8.58

High
8.60

Low
8.35

Prev Close
8.62

Last Trade
4:00

Volume
1.45 m

52 Wk Hi
19.87

52 Wk Low
5.99

Market Cap
1.14 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
135,502,062

EPS (TTM)
0.45

PE Ratio
19.20

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Amarin Corp. plc (AMRN)

Sector News | Topic News

News for AMRN

Tue, Feb 07, 2012

8:00 AM

Amarin to Present at the Leerink Swann 2012 Global Healthcare Conference - Globe Newswire

Mon, Feb 06, 2012

9:00 AM

A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR) - Marketwire

Thu, Feb 02, 2012

9:00 AM

2012 Economic Outlook - Report Highlights Petroleo Brasileiro SA (ADR) and Amarin Corporation plc (ADR) - Marketwire

Wed, Jan 04, 2012

9:27 AM

Amarin Corporation plc Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032 - Globe Newswire

Tue, Jan 03, 2012

4:07 PM

Amarin Corporation plc Announces Offering of $150 Million of Exchangeable Senior Notes Due 2032 - Globe Newswire

6:00 AM

Amarin Commences 2012 With Letter to Shareholders - Globe Newswire

Mon, Dec 19, 2011

4:39 PM

Amarin Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4) - Globe Newswire

Wed, Dec 14, 2011

9:10 AM

Amarin Announces the Addition of Industry Veteran Patrick O'Sullivan to Board - Globe Newswire

Wed, Dec 07, 2011

6:06 AM

Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT - Globe Newswire

Fri, Nov 25, 2011

7:01 AM

Amarin Announces FDA Acceptance for Filing of AMR101 NDA - Globe Newswire

7:00 AM

Amarin Announces Resignation of David Feigal from Board of Directors - Globe Newswire

Mon, Nov 21, 2011

7:00 AM

Amarin Added to NASDAQ Biotechnology Index - Globe Newswire

Wed, Nov 16, 2011

8:16 AM

Volatile Nature of Biotechnology Industry Weighs on Amarin Corporation and Alimera Sciences - Marketwire

7:30 AM

Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011 - Globe Newswire

Tue, Nov 15, 2011

4:15 PM

Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011 - Globe Newswire

Mon, Nov 14, 2011

7:30 AM

Amarin's Phase 3 MARINE and ANCHOR Study Data to be Presented at American Heart Association's Scientific Sessions 2011 - Globe Newswire

Thu, Nov 10, 2011

4:15 PM

Amarin to Present at Two Upcoming Investor Conferences - Globe Newswire

Mon, Nov 07, 2011

6:34 PM

Amarin Reports Third Quarter 2011 Results - Globe Newswire

Thu, Nov 03, 2011

7:00 AM

Amarin Announces Q3, 2011 Results Conference Call - Globe Newswire

Mon, Oct 31, 2011

4:00 PM

Amarin to Ring NASDAQ Closing Bell - Globe Newswire

More News for AMRN >>

Tags for Amarin Corp. plc

Research stocks or mutual funds related to Amarin Corp. plc by keywords or tags. Find companies that have a similar focus to AMRN. The keywords below have been associated to AMRN by either user submission or electronic means.

biotech research parkinsons disease pharmaceuticals research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment pharma strategy pharmaceutical research and development pharmaceutical manufacturing company pharmaceutical advisory boards pharma marketing pharmaceutical software pharma manufacturing huntington's chorea disease huntington's disease pfizer pharmaceutical company kv pharmaceutical company generic products pharmaceutical cro pharma companies American Depository Receipt (ADR) pharmaceutical promotion pharma pharmaceutical distributors biotech pharmaceutical company pharmaceutical development pharmaceutical reports pharmaceutical magazine pharmaceutical consultant Drugs pharma r&d pharmaceutical industry news pharmaceutical manufacturing software physical therapy pharmaceutical manufacturing chorea huntingtons pharmaceutical proteins disorders nervous system contract pharmaceutical pharmaceutical consulting pharmaceutical industry par pharmaceutical patent research pharmaceutical advances pharmaceutical distributor therapeutics products pharmaceutical business development Healthcare huntingtons disease